Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bone marrow transplantation (Basingstoke) 2006-03, Vol.37 (6), p.625-626
Hauptverfasser: Fouillard, L, Serfaty, L, Gozlan, J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 626
container_issue 6
container_start_page 625
container_title Bone marrow transplantation (Basingstoke)
container_volume 37
creator Fouillard, L
Serfaty, L
Gozlan, J
description
doi_str_mv 10.1038/sj.bmt.1705290
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_journals_2642239252</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A182345092</galeid><sourcerecordid>A182345092</sourcerecordid><originalsourceid>FETCH-LOGICAL-c477t-5a195dde4169d4d603c4972f1c4a45dc4c14948594f67046e9e3b8e9787d9a753</originalsourceid><addsrcrecordid>eNp1kktr3DAUhU1paSZpt921iBa681SS9bCWk9AXBLpp10IjXc9osGVXkgfmd-QPV9MYkkKKFhcO3zniXk5VvSF4TXDTfkqH9XbIayIxpwo_q1aESVHzRvDn1QpT0dZNI9RFdZnSAWPCGOYvqwsiGGNUylV1t3HQjUcfUd5DNNMJdWNEvRn8cXY-AIJkzQTIBIf2MJnss0_oGhXHnFAEY7M_FnUMyHQZYpHcbMEhHzKE5PMJ2TE4fyZ82CHT9-MOAniLUoYBWeh7lKMJaepNyH-TXlUvOtMneL3Mq-rXl88_b77Vtz--fr_Z3NaWSZlrbojizgEjQjnmBG4sU5J2xDLDuLPMEqZYyxXrhMRMgIJm24KSrXTKSN5cVR_uc6c4_p4hZX0Y5xjKl5oKRmmjKKeFev9figjBhRKPonamB-1DN5ad7OCT1RvS0oZxrM5R6yeo8hwMvpwJOl_0fwwfHxn2YPq8T2M_n6-Unky2cUwpQqen6AcTT5pgfS6KTgddiqKXohTDu2WreTuAe8CXZhTg7T0QTJ4jPABLwB_5vcPW</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216656965</pqid></control><display><type>article</type><title>Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation</title><source>MEDLINE</source><source>Nature</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Fouillard, L ; Serfaty, L ; Gozlan, J</creator><creatorcontrib>Fouillard, L ; Serfaty, L ; Gozlan, J</creatorcontrib><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/sj.bmt.1705290</identifier><identifier>PMID: 16444277</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Adefovir ; Adenine - analogs &amp; derivatives ; Adenine - therapeutic use ; Adult ; Antineoplastic Agents - therapeutic use ; Care and treatment ; Case studies ; Combined Modality Therapy ; Complications and side effects ; Diagnosis ; Dosage and administration ; Female ; Hematopoietic stem cells ; Hepatitis B ; Hepatitis B - complications ; Hepatitis B virus - isolation &amp; purification ; Hepatitis B virus - physiology ; Humans ; Lamivudine ; Leukemia, Myeloid, Acute - drug therapy ; Leukemia, Myeloid, Acute - therapy ; Organophosphonates - therapeutic use ; Risk factors ; Stem Cell Transplantation ; Stem cells ; Transplantation ; Transplantation Conditioning ; Transplantation, Homologous ; Treatment Outcome ; Viral Load ; Virus Activation ; Viruses</subject><ispartof>Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (6), p.625-626</ispartof><rights>COPYRIGHT 2006 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Mar 2006</rights><rights>Nature Publishing Group 2006.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c477t-5a195dde4169d4d603c4972f1c4a45dc4c14948594f67046e9e3b8e9787d9a753</citedby><cites>FETCH-LOGICAL-c477t-5a195dde4169d4d603c4972f1c4a45dc4c14948594f67046e9e3b8e9787d9a753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,2728,27929,27930</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16444277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fouillard, L</creatorcontrib><creatorcontrib>Serfaty, L</creatorcontrib><creatorcontrib>Gozlan, J</creatorcontrib><title>Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><subject>Adefovir</subject><subject>Adenine - analogs &amp; derivatives</subject><subject>Adenine - therapeutic use</subject><subject>Adult</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Care and treatment</subject><subject>Case studies</subject><subject>Combined Modality Therapy</subject><subject>Complications and side effects</subject><subject>Diagnosis</subject><subject>Dosage and administration</subject><subject>Female</subject><subject>Hematopoietic stem cells</subject><subject>Hepatitis B</subject><subject>Hepatitis B - complications</subject><subject>Hepatitis B virus - isolation &amp; purification</subject><subject>Hepatitis B virus - physiology</subject><subject>Humans</subject><subject>Lamivudine</subject><subject>Leukemia, Myeloid, Acute - drug therapy</subject><subject>Leukemia, Myeloid, Acute - therapy</subject><subject>Organophosphonates - therapeutic use</subject><subject>Risk factors</subject><subject>Stem Cell Transplantation</subject><subject>Stem cells</subject><subject>Transplantation</subject><subject>Transplantation Conditioning</subject><subject>Transplantation, Homologous</subject><subject>Treatment Outcome</subject><subject>Viral Load</subject><subject>Virus Activation</subject><subject>Viruses</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kktr3DAUhU1paSZpt921iBa681SS9bCWk9AXBLpp10IjXc9osGVXkgfmd-QPV9MYkkKKFhcO3zniXk5VvSF4TXDTfkqH9XbIayIxpwo_q1aESVHzRvDn1QpT0dZNI9RFdZnSAWPCGOYvqwsiGGNUylV1t3HQjUcfUd5DNNMJdWNEvRn8cXY-AIJkzQTIBIf2MJnss0_oGhXHnFAEY7M_FnUMyHQZYpHcbMEhHzKE5PMJ2TE4fyZ82CHT9-MOAniLUoYBWeh7lKMJaepNyH-TXlUvOtMneL3Mq-rXl88_b77Vtz--fr_Z3NaWSZlrbojizgEjQjnmBG4sU5J2xDLDuLPMEqZYyxXrhMRMgIJm24KSrXTKSN5cVR_uc6c4_p4hZX0Y5xjKl5oKRmmjKKeFev9figjBhRKPonamB-1DN5ad7OCT1RvS0oZxrM5R6yeo8hwMvpwJOl_0fwwfHxn2YPq8T2M_n6-Unky2cUwpQqen6AcTT5pgfS6KTgddiqKXohTDu2WreTuAe8CXZhTg7T0QTJ4jPABLwB_5vcPW</recordid><startdate>200603</startdate><enddate>200603</enddate><creator>Fouillard, L</creator><creator>Serfaty, L</creator><creator>Gozlan, J</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>200603</creationdate><title>Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation</title><author>Fouillard, L ; Serfaty, L ; Gozlan, J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c477t-5a195dde4169d4d603c4972f1c4a45dc4c14948594f67046e9e3b8e9787d9a753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adefovir</topic><topic>Adenine - analogs &amp; derivatives</topic><topic>Adenine - therapeutic use</topic><topic>Adult</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Care and treatment</topic><topic>Case studies</topic><topic>Combined Modality Therapy</topic><topic>Complications and side effects</topic><topic>Diagnosis</topic><topic>Dosage and administration</topic><topic>Female</topic><topic>Hematopoietic stem cells</topic><topic>Hepatitis B</topic><topic>Hepatitis B - complications</topic><topic>Hepatitis B virus - isolation &amp; purification</topic><topic>Hepatitis B virus - physiology</topic><topic>Humans</topic><topic>Lamivudine</topic><topic>Leukemia, Myeloid, Acute - drug therapy</topic><topic>Leukemia, Myeloid, Acute - therapy</topic><topic>Organophosphonates - therapeutic use</topic><topic>Risk factors</topic><topic>Stem Cell Transplantation</topic><topic>Stem cells</topic><topic>Transplantation</topic><topic>Transplantation Conditioning</topic><topic>Transplantation, Homologous</topic><topic>Treatment Outcome</topic><topic>Viral Load</topic><topic>Virus Activation</topic><topic>Viruses</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fouillard, L</creatorcontrib><creatorcontrib>Serfaty, L</creatorcontrib><creatorcontrib>Gozlan, J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fouillard, L</au><au>Serfaty, L</au><au>Gozlan, J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><addtitle>Bone Marrow Transplant</addtitle><date>2006-03</date><risdate>2006</risdate><volume>37</volume><issue>6</issue><spage>625</spage><epage>626</epage><pages>625-626</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><cop>England</cop><pub>Nature Publishing Group</pub><pmid>16444277</pmid><doi>10.1038/sj.bmt.1705290</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0268-3369
ispartof Bone marrow transplantation (Basingstoke), 2006-03, Vol.37 (6), p.625-626
issn 0268-3369
1476-5365
language eng
recordid cdi_proquest_journals_2642239252
source MEDLINE; Nature; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection
subjects Adefovir
Adenine - analogs & derivatives
Adenine - therapeutic use
Adult
Antineoplastic Agents - therapeutic use
Care and treatment
Case studies
Combined Modality Therapy
Complications and side effects
Diagnosis
Dosage and administration
Female
Hematopoietic stem cells
Hepatitis B
Hepatitis B - complications
Hepatitis B virus - isolation & purification
Hepatitis B virus - physiology
Humans
Lamivudine
Leukemia, Myeloid, Acute - drug therapy
Leukemia, Myeloid, Acute - therapy
Organophosphonates - therapeutic use
Risk factors
Stem Cell Transplantation
Stem cells
Transplantation
Transplantation Conditioning
Transplantation, Homologous
Treatment Outcome
Viral Load
Virus Activation
Viruses
title Adefovir therapy for lamivudine escape and hepatitis B virus reactivation after reduced intensity conditioning allogeneic stem cell transplantation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-11T12%3A38%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adefovir%20therapy%20for%20lamivudine%20escape%20and%20hepatitis%20B%20virus%20reactivation%20after%20reduced%20intensity%20conditioning%20allogeneic%20stem%20cell%20transplantation&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=Fouillard,%20L&rft.date=2006-03&rft.volume=37&rft.issue=6&rft.spage=625&rft.epage=626&rft.pages=625-626&rft.issn=0268-3369&rft.eissn=1476-5365&rft_id=info:doi/10.1038/sj.bmt.1705290&rft_dat=%3Cgale_proqu%3EA182345092%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216656965&rft_id=info:pmid/16444277&rft_galeid=A182345092&rfr_iscdi=true